Dr. Nadine Tung, MD
Claim this profileBeth Israel Deaconess Medical Center
Area of expertise
Breast Cancer
Nadine Tung, MD has run 11 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Nadine Tung, MD has run 5 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
Beth Israel Deaconess Medical Center
Dana Farber Cancer Institute
Clinical Trials Nadine Tung, MD is currently running
T-DM1 vs TH
for Breast Cancer
This research study is studying how well newly diagnosed breast cancer that has tested positive for a protein called HER2 responds using one of two different combination of HER2-directed therapies as a treatment after surgery. The name of the study drugs involved are: * Trastuzumab-emtansine (T-DM1, Kadcyla) * Trastuzumab SC (Herceptin Hylecta) * Paclitaxel
Recruiting
1 award
Phase 2
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting
2 awards
Phase 3
19 criteria
More about Nadine Tung, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Nadine Tung, MD has experience with
- Trastuzumab
- Olaparib
- Paclitaxel
- Pertuzumab
- Quality-of-Life Assessment
- Trastuzumab SC
Breakdown of trials Nadine Tung, MD has run
Breast Cancer
Breast cancer
BRCA2 Mutation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nadine Tung, MD specialize in?
Nadine Tung, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Nadine Tung, MD currently recruiting for clinical trials?
Yes, Nadine Tung, MD is currently recruiting for 5 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Nadine Tung, MD has studied deeply?
Yes, Nadine Tung, MD has studied treatments such as Trastuzumab, Olaparib, Paclitaxel.
What is the best way to schedule an appointment with Nadine Tung, MD?
Apply for one of the trials that Nadine Tung, MD is conducting.
What is the office address of Nadine Tung, MD?
The office of Nadine Tung, MD is located at: Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215 United States. This is the address for their practice at the Beth Israel Deaconess Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.